TY - JOUR
T1 - Ethics versus patient needs - the delicate 'rheostat' for stem cell research
AU - Seach, Natalie Louise
AU - Shannon, Veronica
AU - Boyd, Richard Lennox
PY - 2009
Y1 - 2009
N2 - The isolation of the first human embryonic stem cell (ESC) line, just over a decade ago,1 provided a remarkable catalyst for a new revolution in medical therapies, with the potential to treat a wide variety of debilitating clinical diseases. ESC
technologies have since developed rapidly, but scientists caution that clinical trials are still several years away. However, patient expectations for badly needed treatments are high, placing ever-increasing demands on the ethical and regulatory boundaries and leading to continual public debate and revision of legislation.
AB - The isolation of the first human embryonic stem cell (ESC) line, just over a decade ago,1 provided a remarkable catalyst for a new revolution in medical therapies, with the potential to treat a wide variety of debilitating clinical diseases. ESC
technologies have since developed rapidly, but scientists caution that clinical trials are still several years away. However, patient expectations for badly needed treatments are high, placing ever-increasing demands on the ethical and regulatory boundaries and leading to continual public debate and revision of legislation.
UR - http://search.informit.com.au.ezproxy.lib.monash.edu.au/fullText;dn=200904136;res=APAFT
M3 - Article
SN - 0314-4240
VL - 76
SP - 16
EP - 19
JO - Chemistry in Australia
JF - Chemistry in Australia
IS - 2
ER -